Luchezar Hranov

2.4k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Luchezar Hranov is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Luchezar Hranov has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 4 papers in Cognitive Neuroscience. Recurrent topics in Luchezar Hranov's work include Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Luchezar Hranov is often cited by papers focused on Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Luchezar Hranov collaborates with scholars based in Israel, Italy and Spain. Luchezar Hranov's co-authors include Silvana Galderisi, Han Boter, Sonia Dollfus, Juan J López-Ibor, Jan Libiger, Janusz Rybakowski, Michael Davidson, Joseph Peuskens, Ireneus P.M. Keet and Nils Lindefors and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Schizophrenia Research.

In The Last Decade

Luchezar Hranov

13 papers receiving 1.3k citations

Hit Papers

Effectiveness of antipsychotic drugs in first-episode sch... 2008 2026 2014 2020 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
    2008 784 citations René S. Kahn, W. Wolfgang Fleischhacker et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luchezar Hranov Israel 9 1.1k 319 275 200 179 17 1.3k
Halldóra Jónsdóttir Norway 19 1.3k 1.2× 304 1.0× 217 0.8× 173 0.9× 118 0.7× 24 1.6k
José María Pelayo‐Terán Spain 23 1.3k 1.2× 306 1.0× 250 0.9× 351 1.8× 211 1.2× 57 1.6k
John Abel Engh Norway 20 1.3k 1.2× 303 0.9× 226 0.8× 219 1.1× 118 0.7× 35 1.8k
Obdulia Martínez‐García Spain 25 1.4k 1.3× 342 1.1× 326 1.2× 204 1.0× 187 1.0× 39 1.7k
Haranath Parepally United States 16 986 0.9× 320 1.0× 204 0.7× 141 0.7× 107 0.6× 24 1.2k
Maria A. Rettenbacher Austria 21 963 0.9× 339 1.1× 214 0.8× 287 1.4× 83 0.5× 54 1.5k
Astrid B. Birkenaes Norway 20 1.4k 1.3× 318 1.0× 224 0.8× 186 0.9× 101 0.6× 23 1.9k
René S. Kahn Netherlands 5 805 0.7× 180 0.6× 193 0.7× 96 0.5× 189 1.1× 8 1.1k
J.P. Lindenmayer United States 11 820 0.8× 319 1.0× 189 0.7× 176 0.9× 68 0.4× 17 1.1k
Eva Češková Czechia 21 700 0.6× 234 0.7× 137 0.5× 335 1.7× 134 0.7× 109 1.2k

Countries citing papers authored by Luchezar Hranov

Since Specialization
Citations

This map shows the geographic impact of Luchezar Hranov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luchezar Hranov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luchezar Hranov more than expected).

Fields of papers citing papers by Luchezar Hranov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luchezar Hranov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luchezar Hranov. The network helps show where Luchezar Hranov may publish in the future.

Co-authorship network of co-authors of Luchezar Hranov

This figure shows the co-authorship network connecting the top 25 collaborators of Luchezar Hranov. A scholar is included among the top collaborators of Luchezar Hranov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luchezar Hranov. Luchezar Hranov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dell’Osso, Bernardo, Beatrice Benatti, Humberto Nicolini, et al.. (2017). CHILDHOOD, ADOLESCENT AND ADULT AGE AT ONSET AND RELATED CLINICAL CORRELATES IN OBSESSIVE-COMPULSIVE DISORDER: A REPORT FROM THE INTERNATIONAL COLLEGE OF OBSESSIVE-COMPULSIVE DISORDERS (ICOCS). European Neuropsychopharmacology. 27(6). 610–611.
2.
Ameringen, Michael Van, William Simpson, Beth Patterson, et al.. (2014). Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Journal of Psychopharmacology. 28(6). 596–602. 39 indexed citations
3.
Hranov, Luchezar, et al.. (2014). EPA-0478 – Hyperthymic temperament as a protective factor against suicidal risk. European Psychiatry. 29. 1–1. 1 indexed citations
4.
Hranov, Luchezar, et al.. (2013). Bipolar disorder - from endophenotypes to treatment.. PubMed. 25(3). 284–91. 5 indexed citations
5.
Dell’Osso, Bernardo, Beatrice Benatti, Massimiliano Buoli, et al.. (2013). The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). European Neuropsychopharmacology. 23(8). 865–871. 42 indexed citations
6.
Wobrock, Thomas, Peter Falkai, A. Hasan, et al.. (2013). Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research. 147(1). 132–139. 43 indexed citations
7.
Hranov, Luchezar, et al.. (2013). P.2.d.017 Is hyperthymic temperament an alarming sign?. European Neuropsychopharmacology. 23. S372–S373.
8.
Hranov, Luchezar, et al.. (2012). Electroconvulsive Therapy in Bulgaria. Journal of Ect. 28(2). 108–110. 10 indexed citations
9.
Hranov, Luchezar. (2011). Do neurons have mood and how can it be stabilised?. European Psychiatry. 26(S2). 2050–2050. 1 indexed citations
10.
Bowden, Charles L., Sergey Mosolov, Luchezar Hranov, et al.. (2010). Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. International Clinical Psychopharmacology. 25(2). 60–67. 44 indexed citations
11.
Galderisi, Silvana, Michael Davidson, René S. Kahn, et al.. (2009). Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study. Schizophrenia Research. 115(2-3). 104–114. 95 indexed citations
12.
Davidson, Michael, Silvana Galderisi, Mark Weiser, et al.. (2009). Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST). American Journal of Psychiatry. 166(6). 675–682. 218 indexed citations
13.
Kahn, René S., W. Wolfgang Fleischhacker, Han Boter, et al.. (2008). Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. The Lancet. 371(9618). 1085–1097. 784 indexed citations breakdown →
14.
Hranov, Luchezar. (2007). Comorbid anxiety and depression: illumination of a controversy. International Journal of Psychiatry in Clinical Practice. 11(3). 171–189. 53 indexed citations
15.
Hranov, Luchezar, et al.. (1998). Haloperidol decanoate and fluphenazine decanoate for schizophrenia: A comparative naturalistic medium-term study of efficacy and tolerability. European Neuropsychopharmacology. 8. S213–S213. 2 indexed citations
16.
Hranov, Luchezar, et al.. (1997). P.1.144 Citalopram for the treatment of major depression in the elderly: An open naturalistic study. European Neuropsychopharmacology. 7. S181–S181.
17.
Georgiev, Stanimir & Luchezar Hranov. (1996). P-43 Reversible MAO-A inhibitors in the treatment of panic disorder. European Neuropsychopharmacology. 6. S25–S25. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halldóra Jónsdóttir Breakdown of academic impact, for papers by José María Pelayo‐Terán Breakdown of academic impact, for papers by John Abel Engh Breakdown of academic impact, for papers by Obdulia Martínez‐García Breakdown of academic impact, for papers by Haranath Parepally Breakdown of academic impact, for papers by Maria A. Rettenbacher Breakdown of academic impact, for papers by Astrid B. Birkenaes Breakdown of academic impact, for papers by René S. Kahn Breakdown of academic impact, for papers by J.P. Lindenmayer Breakdown of academic impact, for papers by Eva Češková
Rankless by CCL
2026